HLA-DR expressing peripheral T regulatory cells in newly diagnosed patients with different forms of autoimmune thyroid disease

Thyroid

Volumn 18, Issue 11, 2008, Pages 1195-1200

  Fountoulakis, Stelios ^a   Vartholomatos, George ^b   Kolaitis, Nikolaos ^b   Frillingos, Stathis ^a   Philippou, George ^a   Tsatsoulis, Agathocles ^a,c  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HYPOTHYROIDISM; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; GRAVES DISEASE; HASHIMOTO DISEASE; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; THYROID HORMONES; YOUNG ADULT;

EID: 56549130085     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.0089     Document Type: Article

References (45)

1. Weetman AP 2003 Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 148:1-9.
2. Fountoulakis S, Tsatsoulis A 2004 On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis. Clin Endocrinol (Oxf) 60:397-409.
3. Shevach EM 2006 From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25:195-201.
4. Piccirillo CA, Thornton AM 2004 Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells. Trends Immunol 25:374-380.
5. Baecher-Allan C, Wolf E, Hafler DA 2005 Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+ T cells. Clin Immunol 115:10-18.
6. high regulatory cells in human peripheral blood. J Immunol 167:1245-1253.
7. Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C 2003 Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 33:215-223.
8. Sakaguchi S 2005 Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and nonself. Nat Immunol 6:345-352.
9. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY 2005 Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22:329-341.
10. Walker MR, Kasprowicz DJ, Gersuk VH, Bernard A, Van Landeghen M, Buckner JH, Ziegler SF 2003 Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 112:1437-1443.
11. Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S, Maeda M, Onodera M, Uchiyama T, Fujii S, Sakaguchi S 2004 Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 16:1643-1656.
12. Baecher-Allan C, Wolf E, Hafler DA 2006 MHC Class II expression identifies functionally distinct human regulatory T cells. J Immunol 176:4622-4631.
13. Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T 1985 Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance: deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med 161:72-87.
14. Laurie KL, Van Driel IR, Gleeson PA 2002 The role of CD4+CD25+ immunoregulatory T cells in the induction of autoimmune gastritis. Immunol Cell Biol 80:567-573.
15. Liu H, Hu B, Xu D, Liew FY 2003 CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-β and CTLA4. J Immunol 171:5012- 5017.
16. Morris GP, Chen L, Kong YC 2003 CD137 signaling interferes with activation and function of CD4+CD25+ regulatory T cells in induced tolerance to experimental autoimmune thyroiditis. Cell Immunol 226:20-29.
17. Nagayama Y, Horie I, Saitoh O, Nakahara M, Abiru N 2007 CD4+CD25+ naturally occurring regulatory T cells and not lymphopenia play a role in the pathogenesis of iodide-induced autoimmune thyroiditis in NOD-H2h4 mice. J Autoimmun 29:195-202.
18. Jacob JB, Kong YC, Meroueh C, Snower DP, David CS, Ho YS, Wei WZ 2007 Control of Her-2 tumor immunity and thyroid autoimmunity by MHC and regulatory T cells. Cancer Res 67:7020-7027.
19. Vasu C, Dogan RN, Holterman MJ, Prabhakar BS 2003 Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis. J Immunol 170:5511-5522.
20. Morris GP, Kong YC 2006 Tolerance to autoimmune thyroiditis: (CD4+)CD25+ regulatory T cells influence susceptibility but do not supersede MHC class II restriction. Front Biosci 11:1234-1243.
21. Samy ET, Setiady YY, Ohno K, Pramoonjago P, Sharp C, Tung KSK 2006 The role of physiological self-antigen in the acquisition and maintenance of regulatory T-cell function. Immunol Rev 212:170-184.
22. Aschenbrenner K, D'Cruz LM, Vollman E, Hinterberger M, Emmerich J, Swee LK, Rolink A, Klein L 2007 Selection of FoxP3 regulatory T cells specific for self antigen expressed and presented by Aire medullary thymic epithelial cells. Nat Immunol 8:351-357.
23. Apostolou I, Sarukhan A, Klein L, von Boehmer H 2002 Origin of regulatory T cells with known specificity for antigen. Nat Immunol 3:756-763.
24. McLachlan SM, Nagayama Y, Pichurin PN, Mizutori Y, Chen CR, Misharin A, Aliesky HA, Rapoport B 2007 The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells. Endocrinology 148:5724-5733.
25. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, Ten S, Sanz M, Exley M, Wilson B, Porcelli S, Maclaren N 2002 Multiple immunoregulatory defects in type 1 diabetes. J Clin Invest 109:131-140.
26. + regulatory T cells. Proc Natl Acad Sci USA 102:5150-5155.
27. Coles AJ, Thompson S, Cox AL, Curran S, Gurnell EM, Chatterjee VK 2005 Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory T cells. Eur J Immunol 35:3694-3703.
28. Parietti V, Chifflot H, Muller S, Monneaux F 2007 Regulatory T cells and systemic lupus erythematosus. Ann N Y Acad Sci 1108:64-75.
29. Fattorossi A, Battaglia A, Buzzonetti A, Ciaraffa F, Scambia G, Evoli A 2005 Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment. Immunology 116:134-141.
30. Gessl A, Wilfing A, Agis H, Steiner G, Czernin S, Boltz-Nitulescu G, Vierhapper H, Waldhausl W 1995 Activated naive CD4+ peripheral blood T cells in autoimmune thyroid disease. Thyroid 5:117-125.
31. Corrales JJ, Orfao A, Lopez A, Mories MT, Miralles JM, Ciudad J 1997 Analysis of IL-2 and IL-6 binding to peripheral blood lymphocytes in Graves disease: relationship with disease activity. Cytometry 30:118-123.
32. Watanabe M, Yamamoto N, Maruoka H, Tamai H, Matsuzuka F, Miyauchi A, Iwatani Y 2002 Independent involvement of CD8+CD25+ cells and thyroid autoantibodies in disease severity of Hashimoto's disease. Thyroid 12:801-808.
33. Nakano A, Watanabe M, Iida T, Kuroda S, Matsuzuka F, Miyauchi A, Iwatani Y 2007 Apoptosis-induced decrease of intrathyroidal CD4(+)CD25(+) regulatory T cells in autoimmune thyroid diseases. Thyroid 17:25-31.
34. + regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 199:1285-1291.
35. Venken K, Hellings N, Thewissen M, Somers V, Hensen K, Rummens JL, Medaer R, Hupperts R, Stinissen P 2008 Compromised CD4(+) CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 123:79-89.
36. + T-cells from patients with type 1 diabetes. Diabetes 54:92-99.
37. Brusko TM, Wasserfall CH, Clare-Salzler MJ, Schatz DA, Atkinson MA 2005 Functional defects and the influence of age on the frequency of CD4+CD25+T-cells in type 1 diabetes. Diabetes 54:1407-1414.
38. Tree TIM, Roep BO, Peakman M 2006 A mini meta-analysis of studies on CD4CD25 T cells in human type 1 diabetes. Ann N Y Acad Sci 1079:9-18.
39. + regulatory T-cells in type 1 diabetes. Diabetes 56:604-612.
40. Lin SC, Chen KH, Lin CH, Kuo CC, Ling QD, Chan CH 2007 The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest 3:7987-7996.
41. Battaglia A, Di Schino C, Fattorossi A, Scambia G, Evoli A 2005 Circulating CD4+CD25+ T regulatory and natural killer T cells in patients with myasthenia gravis: a flow cytometry study. J Biol Regul Homeost Agents 19:54-62.
42. + regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin Exp Immunol 147:412-418.
43. Marazuela M, Garcia-Lopez MA, Figueroa-Vega N, de la Fuente H, Alvarado-Sanchez B, Monsivais-Urenda A, Sanchez-Madrid F, Gonzalez-Amaro R 2006 Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab 91:3639-3646.
44. Fountoulakis S, Vartholomatos G, Kolaitis N, Frillingos S, Philippou G, Tsatsoulis A 2008 Differential expression of Fas system apoptotic molecules in peripheral lymphocytes from patients with Graves' disease and Hashimoto's thyroiditis. Eur J Endocrinol 158:853-859.
45. Jiang H, Chess L 2006 Regulation of immune responses by T cells. N Engl J Med 354:1166-1176.